Clay Thorp, Director at Clearside Biomedical, holds 3.59M shares in Clearside Biomedical (Ticker: CLSD), holds 1.56M shares in Vigil Neuroscience Inc (Ticker: VIGL), holds 3.58M shares in Phasebio Pharmaceuticals (Ticker: PHASQ). Most recently, Clay Thorp Bought ― shares of Clearside Biomedical on Sep 25, 2023 for an estimated value of 8.60K.